Patents by Inventor Derek Alan Woodcock

Derek Alan Woodcock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110308516
    Abstract: The invention provides a delivery device (10) for a medicament comprising: a housing (50), a receptacle (54) holding a medicament (80) in the form of a powder; and a source of propellant (53), characterized in that the housing (50) provides an inlet (63) and an outlet (56) for the receptacle (54) wherein the inlet (63) is in fluid communication with the source of propellant (53) and is directed against the medicament (80) and the outlet (56) is spaced from the medicament (80) to allow aerosolisation of the medicament (80); the device (10) provides improved delivery efficiency, particularly a delivered fine particle fraction of greater than 20% by weight.
    Type: Application
    Filed: February 2, 2011
    Publication date: December 22, 2011
    Applicant: Britannia Pharmaceuticals Ltd.
    Inventors: Robert Price, John Nicholas Staniforth, Derek Alan Woodcock, Paul Michael Young
  • Publication number: 20100006095
    Abstract: The application describes apparatus and methods for delivering a powdered medicament for inhalation. The medicament is put in a receptacle (100) on a vibration generator (80) operated by fluid pressure, e.g. by means of an eccentric rotor. A flow of gas from a supply (20) is passed into the receptacle (100), producing in concert with the vibration an aerosol which passes out of the receptacle and along a tube (110) to be inhaled by the patient. Both the gas flow supply and vibration may be subject to the operation of a control unit (60), which may time the production of the aerosol according to a patient's breathing cycle, e.g. as part of a ventilator system.
    Type: Application
    Filed: January 16, 2006
    Publication date: January 14, 2010
    Applicant: BRITANNIA PHARMACEUTICALS LIMITED
    Inventors: Derek Alan Woodcock, Chritopher Pynn, James Thompson
  • Publication number: 20090042840
    Abstract: A phospholipid comprising a diacyl-substituted phosphatidyl group and a pharmaceutical composition comprising such a phospholipid for use in treatment of an allergic inflammatory condition and a method for the treatment of an allergic inflammatory condition. The phospholipid is particularly a mixture of phospholipids known as pumactant.
    Type: Application
    Filed: May 23, 2006
    Publication date: February 12, 2009
    Inventors: Derek Alan Woodcock, Christopher Pynn, Anthony Postle
  • Patent number: 7473416
    Abstract: A method and apparatus are disclosed for treating asthma and other respiratory conditions. A medicament comprising a surface active phospholipid (SAPL) is prepared in the form of a fine powder and administered to the lungs in a gas stream. A preferred SAPL is a solid blend of diplamitoyl choline and phosphatdiyl glycerol (PG).
    Type: Grant
    Filed: November 1, 2004
    Date of Patent: January 6, 2009
    Assignee: Britannia Pharmaceuticals, Ltd.
    Inventors: Audrey Egerton Hills, legal representative, Derek Alan Woodcock, Brian Andrew Hills
  • Patent number: 7273604
    Abstract: Disclosed is a combination product for use in treating asthma and other respiratory conditions comprising a medicament comprising a surface active phospholipid composition in the form of a fine powder and an antiasthma drug. The product is arranged to be administered to the lungs by inhalation, for example, by the disclosed devices.
    Type: Grant
    Filed: October 27, 2004
    Date of Patent: September 25, 2007
    Assignee: Britannia Pharmaceuticals Limited
    Inventors: Brian Andrew Hills, Derek Alan Woodcock, John Nicholas Staniforth
  • Patent number: 6824761
    Abstract: Disclosed is a combination product for use in treating asthma and other respiratory conditions comprising a medicament comprising a surface active phospholipid composition in the form of a fine powder and an antiasthma drug. The product is arranged to be administered to the lungs by inhalation, for example, by the disclosed devices.
    Type: Grant
    Filed: September 17, 2001
    Date of Patent: November 30, 2004
    Assignee: Britannia Pharmaceuticals Limited
    Inventors: Brian Andrew Hills, Derek Alan Woodcock, John Nicholas Staniforth
  • Patent number: 6719960
    Abstract: A medicament is disclosed for reducing the risk of cross-healing (“adhesions”) after surgery. The medicament is a dry powder comprising a surface active phospholipid which is capable of binding to mesothical membranes, and a spreading agent. The medicament is applied as a dry powder to the surgical wound site.
    Type: Grant
    Filed: August 10, 2000
    Date of Patent: April 13, 2004
    Assignee: Britannia Pharmaceuticals Ltd.
    Inventors: Brian Andrew Hills, Derek Alan Woodcock
  • Publication number: 20030044357
    Abstract: A method and apparatus are disclosed for treating asthma and other respiratory conditions. A medicament comprising a surface active phospholipid (SAPL) is prepared in the form of a fine powder and administered to the lungs in a gas stream. A preferred SAPL is a solid blend of diplamitoyl choline and phosphatdiyl glycerol (PG).
    Type: Application
    Filed: November 12, 2002
    Publication date: March 6, 2003
    Inventors: Brain Andrew Hills, Derek Alan Woodcock
  • Patent number: 6482391
    Abstract: A method and apparatus is disclosed for treating asthma and other respiratory conditions. A medicament comprising a surface active phospholipid (SAPL) is prepared in the form of a fine powder and administered to the lungs in a gas stream. A preferred SAPL is a solid blend of dipalmitoyl phosphatidyl choline (DPPC) and phosphatidyl glycerol (PG).
    Type: Grant
    Filed: August 10, 2000
    Date of Patent: November 19, 2002
    Assignee: Britannia Pharmaceuticals Limited
    Inventors: Brain Andrew Hills, Derek Alan Woodcock
  • Patent number: 6395295
    Abstract: The invention relates to the treatment of serous otitis media (glue ear). A medicament is disclosed which comprises a surface active phospholipid (SAPL) which is instilled as a powder into the middle ear. The SAPL has an affinity for the surface of the Eustachian tube and forms a film over its surface which prevents or deters reblockage of the tube.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: May 28, 2002
    Assignee: Britannia Pharmaceuticals Limited
    Inventors: Brian Andrew Hills, Derek Alan Woodcock